Home » A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
by Gu, Liangyou, Peng, Cheng, Liang, Qiyang, Huang, Qingbo, Lv, Deqiang, Zhao, Houming, Zhang, Qi, Zhang, Yu, Zhang, Peng, Li, Shichao, Xu, Junnan, Chen, Luyao, Xie, Yongpeng, Li, Jinhang, Guo, Gang, Zhang, Xu, Wang, Baojun & Ma, Xin | Oct 4, 2024 | Articles |
